Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting
the humoral immune system. Intravenous preparations have a number of important uses in
the treatment of other diseases in humans as well, some for which acceptable treatment
alternatives do not exist. We provide an update of the evidence-based guideline on
immunoglobulin therapy, last published in 2006. Given the potential risks and inherent …